组别 | 例数 | 治疗前 | 治疗后观察时间 | t | p | |
2周 | 4周 | |||||
HAMD评分 | ||||||
实验组 | 50 | 16.06 ± 3.85 | 11.04 ± 2.55 | 4.94 ± 1.75 | 20.9952 | <0.001 |
对照组 | 50 | 15.86 ± 4.08 | 13.08 ± 2.86 | 9 ± 3.21 | 15.9356 | <0.001 |
t |
| 0.5092 | −5.9716 | −9.1268 |
| |
p | 0.6129 | 0.0000 | 0.0000 | |||
PSQI评分 | ||||||
实验组 | 50 | 14.28 ± 3.45 | 10.64 ± 2.79 | 6.36 ± 2.27 | 18.9135 | <0.001 |
对照组 | 50 | 14.06 ± 3.01 | 11.12 ± 2.08 | 7.37 ± 2.36 | 14.8697 | <0.001 |
t |
| 0.3593 | −1.8196 | −2.5504 |
| |
p | 0.7209 | 0.0749 | 0.0139 |